⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15840377 | 1.00 | — | — | |
| SCHEMBL215360 | 1.00 | — | — | |
| SCHEMBL6314499 | 1.00 | — | — | |
| SCHEMBL17867090 | 1.00 | — | — | |
| SCHEMBL6314501 | 1.00 | — | — | |
| SCHEMBL215359 | 1.00 | — | — | |
| SCHEMBL15106958 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL738528 | 0.97 | DPP4 (0.47) | — | |
| Hydrochloric Acid SCHEMBL738527 | 0.97 | DPP4 (0.47) | — | |
| Hydrochloric Acid SCHEMBL6556151 | 0.97 | DPP4 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102388039-B | pyrazole derivatives as CCR4 receptor antagonists | GLAXO GROUP LTD | 2015-07-15 | — | — | CN | claimed |
| CN-102573879-A | Cathepsin C inhibitors | GLAXO GROUP LTD | 2012-07-11 | — | — | CN | claimed |
| CN-101657211-A | Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity | AETERNA ZENTARIS GMBH DE | 2010-02-24 | — | — | CN | claimed |
| US-6949658-B2 | Process for producing optically active α-amino acid and optically active α-amino acid amide | MITSUBISHI RAYON CO., LTD. (JP) | 2005-09-27 | — | — | US | claimed |
| CN-1599720-A | Tetrahydrocarbazole derivatives as ligands for G-protein coupled receptors (GPCRs) | ZENTARIS AG (DE) | 2005-03-23 | — | — | CN | claimed |
| US-5519000-A | OLIGOPEPTIDE | CENTECOR, INC. (US) | 1996-05-21 | — | — | US | claimed |
| US-5486595-A | Tumor necrosis factor inhibitors | CENTECOR, INC. (US) | 1996-01-23 | — | — | US | claimed |
| WO-1995026744-A1 | TUMOR NECROSIS FACTOR INHIBITORS | CENTOCOR, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| EP-4684030-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024227957-A2 | METHOD OF DEPROTECTING AT LEAST ONE D-AMINO ACID AND/OR D-AMINO ACID DERIVATIVE PROTECTED FUNCTIONAL GROUP | Martin-Luther-Universität Halle-Wittenberg (DE) | 2024-11-07 | — | — | WO | disclosed |
| US-20240366738-A1 | MOLECULAR VACCINES FOR INFECTIOUS DISEASE | AGILENT TECHNOLOGIES INC (US) | 2024-11-07 | — | — | US | disclosed |
| CN-118530973-A | Stabilized cellulase variants | 诺维信公司 | 2024-08-23 | — | — | CN | disclosed |
| CN-118460512-A | Stabilized cellulase variants | 诺维信公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-1086810-A | Condensed heterocyclic derivative and agricultural or horticultural fungicide containing the same | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1994-05-18 | — | — | CN | disclosed |
| CN-1062536-A | Retroviral protease inhibitors from 3-chloro-2-chloromethyl-1-propylene derived | AMERICAN CYANAMID CO (US) | 1992-07-08 | — | — | CN | disclosed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | disclosed |
| CN-1053607-A | The human immunity that is used for the treatment of AIDS lacks the inhibitor of virus protease | MERCK & CO INC (US) | 1991-08-07 | — | — | CN | disclosed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | disclosed |